Nebius Just Raised $5 Billion in Convertible Notes Against a $1.4 Billion Revenue Base. Are We In a Bubble?

Nebius priced an upsized $5.0B convertible senior notes offering (from $4.5B proposed), with two tranches due 2030 ($3.0B at 0.50% and ~40% conversion premium) and 2034 ($2.0B at 4.50% and ~45% premium). Net proceeds are about $4.94B, funding $5.7B/quarter AI data-center and GPU buildout, but with capital spending roughly 10x revenue (Q2 revenue $582.3M) raising dilution and repeat-funding risk. The deal also includes $400M exchanges into ~15.8M shares of existing converts and could imply ~6% dilution at initial conversion levels; shares fell ~10% on the initial announcement.

Analysis

The market is not just pricing dilution; it is pricing a business model that still needs external capital to outrun depreciation. When a company raises this much against a revenue base this small, the real signal is that equity is being used as a loss-absorbing buffer for a very rapid asset buildout, and that usually keeps the multiple capped until utilization and cash conversion catch up. The convert structure softens the immediate funding shock, but it also creates a multi-year overhang: every rally toward the conversion price increases the chance that upside is partially recycled into dilution rather than permanent equity value.

Second-order beneficiaries are the equipment and infrastructure layer, not the operator. GPU suppliers and power/colocation vendors get the demand pull-forward, while other capital-intensive AI cloud names will likely trade more like financing stories than growth stories if investors extrapolate this template. The more important read-through is for the convertible and high-yield markets: repeated mega-raises from still-unproven AI infrastructure names can widen spreads for peers with similar capex/revenue gaps, even if the end-demand narrative remains intact.

Near term, the catalyst path is about flow and sentiment: settlement removes one funding overhang but also validates that another raise was needed quickly, so the stock can stay pressured for days to weeks. Over 1-3 months, the key test is whether prepayments, contract wins, and utilization data start shrinking incremental capital needs; if not, this likely becomes a recurring financing story. Over 6-18 months, the thesis breaks if Nebius can translate contracted capacity into visible free cash flow before the next financing window, because the current risk is not liquidity today but a ratchet of future dilution.

Key Decisions for Investors

• Short NBIS on post-settlement strength for a 1-3 month horizon; thesis is multiple compression from financing overhang and dilution risk. Cover if the stock reclaims the pre-offering high and management shows a clear path to self-funding cash flow.
• Pair trade: long NVDA / short NBIS for 1-3 months. The supplier captures the capex cycle with less balance-sheet risk, while NBIS carries the financing and depreciation burden. Falsify if NBIS reports utilization and gross margin expansion that materially reduce future capital needs.
• If options liquidity allows, buy a 3-6 month NBIS put spread rather than outright short equity to express the funding-overhang view with defined risk. Best entry is after any relief rally, not immediately after the placement.
• Set an alert for any new debt/equity raise or incremental capex guidance from NBIS over the next 1-2 quarters; another financing round would be the strongest confirmation that current equity is still being used as bridge capital.
• Do not short the AI supplier complex broadly off this headline alone; use this as a relative-value signal in capital-intensive AI infra names, not a sector-wide demand collapse call.